Alzamend Neuro, Inc. (ALZN) stock
ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
$1.13−0.05 (-4.24%)
Close on Nov 17, 2026Market cap $5.45MP/E –Yield –
Alzamend Neuro enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Alzamend Neuro's enterprise value was -$1.27M on Nov 11, 2026, against $1.26M a year earlier. Over the last 5 years it ranged from -$2.20M to $587.38M, with a median of $4.86M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.27M | -151.4% |
| 2025 | Dec 31, 2025 | $2.47M | – |
| 2024 | Dec 31, 2024 | -$194.79K | -103.5% |
| 2023 | Dec 29, 2023 | $5.56M | -87.6% |
| 2022 | Dec 30, 2022 | $44.76M | -73.7% |
| 2021 | Nov 30, 2021 | $170.31M | – |
See a number that looks wrong?